I am perfectly prepared to accept that it is a worst-case scenario, but we are dealing with projections that are based on a great deal of speculation, and they do not take account of the possibility of new variants. I rather share the concern expressed by some Members in the debate that we need restrictions on
people coming into this country, particularly from the continent, and that there should be more testing of people coming here. I am sure that the Government will want to implement those measures if they can. It is rather easier to call for them to implement them than to do so without causing a great deal of disruption.
I want to briefly touch on the continuation of our vaccination programme. One of the risks that we need to factor in is that the rate of vaccination will slow, and particularly the rate of first doses, because the vaccination programme now has to cope with the large quantity of second doses. The restrictions on vaccine supply mean that the number of first doses will perhaps reduce to as little as 50,000 a week in April. That does not rule out that we should adopt a generous attitude towards our European friends, however much they may be casting around for blame and trying to salvage their reputation from the failure of their own vaccination programmes. We can draw comfort from the fact that they are resorting to possible bans and blockades because they have no contractual obligations to enforce upon AstraZeneca—it is a misunderstanding of the difference between contracts that give rights over stock that exists and contracts that give rights over the flow of production, which is creating stock that does not yet exist.
The fact is that we are at the front of the queue, but I think that the United Kingdom should seek to be generous and to avoid this vaccine nationalism, even if it means giving up some of the flow of our vaccine, although it is understood that there are actually some large quantities of vaccine in the European Union that are not being used. The fact that they have trashed the reputation of the AstraZeneca vaccine is most unfortunate, and while understandable in psychological terms, it is unforgivable in public health terms.
Finally, on the issue of lifting covid restrictions in Parliament, I congratulate my hon. Friend the Member for Hazel Grove (Mr Wragg), the Chair of the Public Administration and Constitutional Affairs Committee, who cobbled together a majority in the Procedure Committee to get what he wanted in the Committee’s report. But I suggest that, in the end, it is a matter for the whole House what the House’s procedures are. There are things to learn, as the Prime Minister said yesterday, that will make the House more equal, fairer to people who are sick and fairer to people who have caring responsibilities and perhaps take the pressure off the shortage of time we have because we do not want too many late nights. Some of our debates have got too short, and speeches have got too short, and if those who had to be away could have proxy votes, we could have longer debates, better debates and better scrutiny of legislation, as well as a House that is more attractive for women to stay in and take part in.